Company Statements
Filter By Year
June 20, 2024
Access Planning in High-Incidence, Resource-Limited Countries for Lenacapavir for HIV Prevention
June 4, 2024
Gilead Statement on Agreement in Principle to Resolve Federal TDF Litigation
April 6, 2024
Gilead Statement on Uganda's Anti-Homosexuality Act
February 15, 2024
Gilead Statement on Magrolimab Studies in Solid Tumors
February 7, 2024
Gilead Statement on Discontinuation of Phase 3 ENHANCE-3 Study in AML
Filter By Year
Some of the content on this page is not intended for users outside